Mrs Rose Hamershock
Brigham and Women's Hospital, Boston (United States of America)
Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial
Event: ESC Congress 2018
Topic: Biostatistics
Session: Atrial fibrillation, stroke and cardiovascular risk
ESC 365 is supported by
